TL;DR
This paper introduces SGUQ, a staged graph convolutional network that efficiently diagnoses Alzheimer's disease by selectively integrating multi-omics data, reducing costs and improving accuracy over existing methods.
Contribution
The paper presents a novel staged GCN with uncertainty quantification that adaptively incorporates multi-omics data for AD diagnosis, enhancing efficiency and accuracy.
Findings
46.23% samples predicted with single-omics data
16.04% samples improved with two-omics data
Achieved 0.858 accuracy on ROSMAP dataset
Abstract
Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the leading cause of dementia, significantly impacting cost, mortality, and burden worldwide. The advent of high-throughput omics technologies, such as genomics, transcriptomics, proteomics, and epigenomics, has revolutionized the molecular understanding of AD. Conventional AI approaches typically require the completion of all omics data at the outset to achieve optimal AD diagnosis, which are inefficient and may be unnecessary. To reduce the clinical cost and improve the accuracy of AD diagnosis using multi-omics data, we propose a novel staged graph convolutional network with uncertainty quantification (SGUQ). SGUQ begins with mRNA and progressively incorporates DNA methylation and miRNA data only when necessary, reducing overall costs and exposure to harmful tests. Experimental results indicate that 46.23% of the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
